Designing better proteins usually takes round after round of trial and error. A new machine learning framework can do it in a single pass — predicting which combinations of mutations will work well together. It could speed up drug design and gene editing.
https://t.co/Sx7VjyQvoW
Despite progress in drug discovery, approximately 90% of druggable disease targets still lack small-molecule therapies.
Although virtual screening can accelerate hit identification, traditional methods such as molecular docking remain too slow for genome-scale applications.
In a new Science study, researchers introduce DrugCLIP, a contrastive learning framework that virtually screens small molecules and protein pockets, analyzing protein-ligand interactions 10 million times faster than most standard molecular docking approaches. https://t.co/zr0CdXAaug
We're still accepting applications for poster presentations at the CECAM conference "RNA We're still We are sill accepting applications for poster presentation at 'RNA Modelling Across Scales" conference. Apply now: https://t.co/vohRDdDOVo Organized with @BussiGio@devivo_marco
Calling the #moleculardynamics community – first CASP target ever for predicting water (ensembles) around a macromolecule: https://t.co/HrYSuBFTMq Will be evaluated by direct comparison to #cryoEM on the Tetrahymena ribozyme #RNA!
#CASP16 has begun! First #RNA target R1203 is available for 3D structure prediction. It's an important regulatory element in HIV. Will #deeplearning outperform humans? https://t.co/NpoqWqtY7U
🚨 APOBEC3B (A3B) is a major source of🧬mutation in cancer
The active site is like Teflon (not much binds) BUT @Ozlem__Dmr discovered a druggable allosteric site 👀
Experiments by @DanHarki@_ChemKat@HarrisLabUTHSA 💪
https://t.co/sAdFy42Mw0
New competition to develop machine learning (ML) models to predict the binding affinity of small molecules to specific protein targets using the Big Encoded Library for Chemical Assessment (BELKA). With prizes! Deadline 9 July 2024. #drugdesign
https://t.co/nV29LaI074